Peritubular Capillary Basement Membrane Multilayering in Renal Allograft Biopsies of Patients With De Novo Donor-Specific Antibodies-Reference-Cited by-同舟云学术

Peritubular Capillary Basement Membrane Multilayering in Renal Allograft Biopsies of Patients With De Novo Donor-Specific Antibodies

Published:2016-04 Issue:4 Volume:100 Page:889-897
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

de Kort Hanneke,Willicombe Michelle,Brookes Paul,Moran Linda B,Santos-Nunez Eva,Galliford Jack W.,Taube David,McLean Adam G.,Moss Jill,Cook H. Terence,Roufosse Candice

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference32 articles.

1. Identifying specific causes of kidney allograft loss;El-Zoghby;Am J Transplant,2009

2. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence;Sellarés;Am J Transplant,2012

3. Transplant glomerulopathy: subclinical incidence and association with alloantibody;Gloor;Am J Transplant,2007

4. Early ultrastructural changes in renal allografts: correlation with antibody-mediated rejection and transplant glomerulopathy;Haas;Am J Transplant,2011

5. Peritubular capillary basement membrane multilayering on electron microscopy: a useful marker of early chronic antibody-mediated damage;Roufosse;Transplantation,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation;Transplant International;2022-05-20

2. Clinical–pathological correlations in post‐transplant thrombotic microangiopathy;Histopathology;2019-06-23

3. The relationship between pathologic lesions of active and chronic antibody-mediated rejection in renal allografts;American Journal of Transplantation;2018-09-24

4. Correlations between donor-specific antibodies and non-adherence with chronic active antibody-mediated rejection phenotypes and their impact on kidney graft survival;Human Immunology;2018-06

5. Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation;American Journal of Transplantation;2017-10-24